Big Pharma Gets 77,500% Return On Lobbying Investment

04/04/2012 18:41

Source: United Republic

Investing is a time-honored American tradition. Millions of Americans have some sort of investment, and the stock market is an honored cultural institution. But investing your money in a publicly traded company isn’t the only way to make a buck. Let’s say you’re a powerful industry that wants to make a lot of money with an enormous Return On Investment (ROI). One way you could do so is by investing in lobbyists.

We here at United Republic have put together some stats about the sort of ROI Big Money expects for its lobbying dollars in Washington. As one example, an average American can expect a ROI of 11 percent for investing in one Blue Chip stock in the Dow Jones Industrial Average in 2010. Meanwhile, Big Pharma has a ROI of 75,500 percent for the lobbying dollars it spends to bar the government from bargaining for cheaper drug prices through Medicare:

 

 

Of course, that money that Pharma and the rest of the industries on the chart are making is at expense of American taxpayers and American consumers. But as long as we have a political system that bends to the whims of Big Money, the best ROI you can get is to be a lobbyist.

Zaid Jilani is the Communications and Outreach Coordinator for United Republic. He previously served as the Senior Reporter-Blogger for ThinkProgress, and his work has also appeared in outlets including Salon and the Atlanta Journal-Constitution.

Please note : The content on this site does not always express the viewpoints of the site owner

Many topics are covered and links given, so that you can do your own research

 

FAIR USE NOTICE: These pages/video may contain copyrighted (© ) material the use of which has not always been specifically authorized by the copyright owner. Such material is made available to advance understanding of ecological, Political, Human Rights, economic, scientific, Moral, Ethical, and Social Justice issues, etc. It is believed that this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior general interest in receiving similar information for research and educational purposes.

globalnoncompliance.net